Royal Bank of Canada’s Jaguar Health JAGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Hold
1
– – ﹤0.01% 7576
2026
Q1
$0 Hold
1
– – ﹤0.01% 7400
2025
Q4
$1K Hold
1
– – ﹤0.01% 7002
2025
Q3
$2K Hold
1
– – ﹤0.01% 6885
2025
Q2
$2K Hold
1
– – ﹤0.01% 6801
2025
Q1
$3K Buy
+1
New +$8.48K ﹤0.01% 6496
2024
Q2
– Hold
0
– – – 7293
2024
Q1
– Hold
0
– – – 7286
2023
Q4
– Hold
0
– – – 7346
2023
Q3
– Hold
0
– – – 7323
2023
Q2
– Hold
0
– – – 7441
2023
Q1
– Hold
0
– – – 7266
2022
Q4
– Hold
0
– – – 7464
2022
Q3
– Hold
0
– – – 7639
2022
Q2
– Hold
0
– – – 7538
2022
Q1
– Hold
0
– – – 7877
2021
Q4
– Hold
0
– – – 7780
2021
Q2
– Hold
0
– – – 7576
2021
Q1
– Hold
0
– – – 7550

Other funds holding JAGX

Royal Bank of Canada's JAGX Position: Q2 2026 in Review

Royal Bank of Canada held its Jaguar Health (JAGX) position steady in Q2 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7576.

Royal Bank of Canada first reported a position in JAGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $3K in Q1 2025. 5 funds tracked by Wall St. Rank hold JAGX as of Q2 2026.

  • Royal Bank of Canada held 1 share of Jaguar Health worth $0 as of Q2 2026.
  • Royal Bank of Canada left its Jaguar Health share count unchanged in Q2 2026.
  • Jaguar Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7576 holding.
  • Royal Bank of Canada first reported a position in Jaguar Health in Q1 2025 and has held it in 6 quarters since.
  • Royal Bank of Canada's Jaguar Health position peaked at $3K in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Jaguar Health as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.